The 13th International Conference on Environmental Mutagens: Maintaining Genomic Health in a Changing World will be held in Ottawa, Canada, August 27 – September 1, 2022. This conference will be part of the 52nd Annual Meeting of the Environmental Mutagenesis & Genomics Society.
Below is a list of confirmed keynote speakers (and topics) for the conference, which will be held at the Westin Hotel and Conference Centre in Ottawa.
The conference will be opened by local government officials, with opening remarks provided by Dr. Mona Nemer, Chief Science Advisor to the Governmental of Canada.
- Adebowale Adeyemo, Deputy Director, Center for Research on Genomics and Global Health, NIH: Genomic determinants of health and environmental interactions
- Linda Birnbaum, former Director of the U.S. National Institute of Environmental Health Sciences: Climate change and emerging public health issues
- Cynthia Burrows, Distinguished Professor, Department of Chemistry, University of Utah:
- Chemical modifications of DNA and RNA bases, understanding cellular function of base modifications
- Amander Clark, Chair of the Department of Molecular Cell and Developmental Biology, UCLA: Germ cell development, epigenetic programming, novel models
- Stephen Scherer, Director, Center for Applied Genomics, Hospital for Sick Children, Toronto: Genetic variation in the human genome and disease susceptibility
- Sir Michael Stratton, Director of the Wellcome Trust Sanger Institute: Human genomics and cancer mutational signatures
- Ulla Vogel, Senior Research Professor, National Center for the Working Environment, Copenhagen, Denmark : Human health safety assessments and regulation of manufactured nanomaterials
- Graham Walker, Massachusetts Institute of Technology, member of US National Academy of Sciences: Recent advances in understanding of DNA repair processes
- Maurice Whelan, Director of Systems Toxicology, European Center for Validation of Alternative Methods, European Commission Joint Research Center, Ispra, Italy: (Geno)toxicity testing in the 21st century; alternatives to animal testing
- Sunney Xie, Director of the Biomedical Pioneering Innovation Center, Peking University: Single cell genomics and chromatin architecture
- Mayana Zatz, Director of the Human Genome and Stem Cell Research Center, University of Sao Paulo: Genetic basis of human neuromuscular diseases
- Kym Boycott (Local Spotlight), Professor, Department of Pediatrics, Faculty of Medicine, University of Ottawa; Chair, International Rare Disease Research Consortium (IRDiRC), Diagnostics Committee: Molecular basis of rare genetic diseases
For more information go to: https://www.emgs-us.org/page/about-ottawa